Edwards Lifesciences Corporation

NYSE:EW

Medical - Devices

Healthcare
$105.23 +0.57%

+$0.49 today

Market cap
$60.51B
Beta
0.87
P/E (TTM)
46.2
EPS (TTM)
$1.89
52W Low $72.30High $89.60

Volume 3.92M

Average 5.02M

EW Pre-Tax Margin

Income before tax as a percentage of revenue.

Edwards Lifesciences CorporationNYSE: EW

Pre-Tax Margin · Q2 FY2026 · quarter ended Jun 2026

Pre-tax margin widens to 29.9%

Pre-tax margin was 29.9% in Q2 FY2026, up 3.7 pp from a year earlier. On a trailing-twelve-month basis it was 21.8%, down 6.9 pp year over year. Over 3 fiscal years it narrowed by 11.9 pp.

Context

  • Pre-tax margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
29.9%+2.0 pp QoQ
Last fiscal yearDec 2025
21.0%-7.5 pp YoY
LTMJun 2026
21.8%-6.9 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.7 pp——
1 year-7.5 pp——
3 years-11.9 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
21.0%
Year-over-year change
-7.5pp

Pre-Tax Margin vs competitors

How EW compares with its peers on the latest reported figures

  • EW's LTM Jun 2026 pre-tax margin of 21.8% is the 2nd highest of the 6 companies compared; the peer median is 7.9%.
  • Its year-over-year change of -6.9 pp is the 5th highest of 6, against a peer median of +0.0 pp.
  • Over three fiscal years its change of -11.9 pp compares with a peer median of +7.1 pp.
EW Competitors Peer median
Pre-Tax Margin for EW and competitors
Company Period LTM level YoY 3-year change
ISRGIntuitive Surgical, Inc.LTM Sep 202631.3% -1.7 pp+7.1 pp
EWEdwards Lifesciences CorporationLTM Jun 202621.8% -6.9 pp-11.9 pp
PENPenumbra, Inc.LTM Jun 202613.5% +0.0 pp+14.2 pp
LIVNLivaNova PLCLTM Sep 20267.9% +22.2 pp-8.5 pp
AORTArtivion, Inc.LTM Mar 20263.8% +9.6 pp+8.1 pp
AVRAnteris Technologies Global Corp.LTM Mar 2026-5116.2% -1836.7 pp-3970.6 pp
Peer median (excluding EW) 7.9%+0.0 pp+7.1 pp

Competitors are the stored peer set for EW. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.23B5.38B5.01B5.44B6.07B
Cost of Revenue1.23B1.17B1.04B1.12B1.33B
Gross Profit4.01B4.22B3.97B4.32B4.74B
Gross Margin76.6%78.3%79.3%79.5%78.1%
Research & Development903.1M945.2M962.9M1.05B1.08B
Selling, General & Admin1.49B1.57B1.58B1.79B2.09B
Operating Expenses2.4B2.51B2.55B2.94B3.1B
Depreciation & Amortization134.8M139.6M144.9M155.2M156.6M
EBITDA1.86B1.93B1.53B1.72B1.43B
EBITDA Margin35.6%35.9%30.6%31.7%23.6%
Operating Income1.61B1.7B1.43B1.38B1.64B
Operating Margin30.8%31.6%28.5%25.3%27.0%
Interest Income17.4M35.5M67.2M120.3M148.4M
Interest Expense24.8M26.2M17.6M19.8M0
Other Income / Expenses91.6M65M(54.9M)169.4M(363.3M)
Income Before Tax1.7B1.77B1.37B1.55B1.27B
Pre-Tax Margin32.5%32.8%27.4%28.5%21.0%
Income Tax Expense198.9M245.5M152.4M152.1M216.9M
Net Income1.5B1.52B1.4B4.17B1.07B
Net Margin28.7%28.3%28.0%76.7%17.7%
EPS (Basic)2.412.462.316.981.84
EPS (Diluted)2.382.442.306.971.83
Weighted Avg Shares623.3M619M606.7M597.7M584.8M
Weighted Avg Shares (Diluted)631.2M624.2M609.4M599.3M585.8M

Edwards Lifesciences Corporation

NYSE:EW

Intrinsic Alpha fair value

Locked

Current Price

$105.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.